OKKI Go Permissions and Sales Intelligence Software: A Procurement Perspective

The Short Answer on OKKI Go Permissions

OKKI Go requires read-write access to your team's email accounts (Gmail or Outlook), your LinkedIn profile, your CRM contacts, and your calendar. That is not unusual for prospecting tools. What made our IT lead hesitate for 11 days was not the feature list—it was the scope of email access. Read-only is one thing. "Send on behalf of" and "delete messages" is another.

If you only have 30 seconds: get the email permission scope reviewed by IT before you test anything else. Everything below is the order I would evaluate it in, based on an actual review we ran in early 2025.

Why I Got Pulled Into This

I'm an office administrator for a 140-person company. I manage software procurement across roughly 14 vendors—about 60 SaaS contracts annually, renewals included. Software evaluations land on my desk because someone needs a budget approval, a security review, or (more often than I'd like) both at once.

Our VP of Sales asked me to look into OKKI Go in January 2025. I had never heard of "agent-native prospecting" before. I knew sales intelligence software because we already paid for an enrichment tool and two email verification services. I just didn't know what was different about an agent-native one.

I needed three things: what permissions it needs, what it actually does, and when it's worth using.

What OKKI Go Actually Needs Access To

From our review and the vendor's documentation, the permissions fall into roughly three buckets:

• Email account (read-write) — to send, track opens and clicks, and read replies. This is where our IT team spent most of their review time.
• LinkedIn account access — for outreach and contact extraction.
• CRM and calendar — for contact/deal sync and meeting scheduling.

The one thing nobody tells you upfront: where does the data live (vendor servers or local), and for how long? When customer data is involved, our company requires that answer in writing. If you're evaluating this, ask for it in writing too (not that verbal reassurances hold up in procurement—they don't).

Sales Intelligence Software Features—What Matters

OKKI Go covers prospect discovery, enrichment, intent signals, sequencing, and analytics. Most sales intelligence tools cover the same territory. What separates them, in my experience, is data accuracy and coverage.

Enrichment is the piece worth digging into. A single data source typically covers maybe 40% to 60% of a target list (which, honestly, is probably generous). Waterfall enrichment—cascading through multiple databases—pushes coverage higher because each vendor has different gaps. OKKI Go markets this heavily, and it's a real difference. But here's the counterintuitive part: waterfall enrichment is often *slower* per record, not faster. If your team runs small, hand-curated lists, you probably won't notice. If you're pushing 5,000 contacts a week, you absolutely will.

I went back and forth between a cheaper tool with weaker enrichment and a pricier one with better data for about two weeks. On paper, the cheaper tool made sense. But our sales team had been burned before by bounced lists—and a re-verification pass after our last data purchase cost us more time than the tool ever saved.

Email Deliverability—The Part Most Teams Get Wrong

Email deliverability is not the same as sending volume. I only believed that after we ignored it once and watched a quarter of our outbound land in spam folders.

The technical side matters: SPF, DKIM, and DMARC records need to be configured before you send anything. Per FTC CAN-SPAM guidance, commercial messages must include a clear opt-out mechanism, accurate sender information, and non-deceptive subject lines. Penalties can reach $51,744 per email. Compliance, though, is the floor—not the ceiling. Domain reputation, sending limits, and list hygiene determine whether the email ever reaches an inbox.

Our last vendor promised "guaranteed deliverability" in their pitch. I didn't believe it then. I don't believe it now. No tool guarantees inbox placement; they improve your odds.

It took me about three years and two embarrassing bounce-rate incidents to understand that deliverability is mostly an infrastructure problem, not an outreach-tool problem.

What Is Sales Email, and When Should a B2B Team Use It?

Sales email is outbound communication sent to a prospect you have some reason to contact—not a purchased list. That distinction is the whole ballgame for B2B.

Three situations where it earns its keep:

1. Warm(ish) leads. Someone downloaded a whitepaper or attended a webinar. A personalized sales email converts far better than a cold blast.
2. Account-based motions. You've identified 50 target accounts and you're going after them one by one. Sales email is the right channel; mass email is not.
3. Re-engagement. A prospect went quiet 60 days ago. A short, specific follow-up ("you mentioned X, we shipped Y") restarts the conversation more often than another call.

When *not* to use it: transactional communication, customer support follow-ups, or anything a prospect explicitly opted out of. That's not sales email—that's bad practice, and it gets your domain burned.

Where OKKI Go Fits—and Where It Doesn't

If you have a small sales team (three or fewer reps), manual prospecting with a spreadsheet is probably sufficient. Adding a tool at that size introduces overhead—permissions, training, data hygiene—that may not pay back.

If your product-market fit is still unclear, a prospecting tool amplifies whatever motion you already have. That cuts both ways. Our sales VP pushed for OKKI Go before we had a clean ICP definition, and I pushed back for two weeks until we had one. The tool is the accelerant, not the fuel.

One more boundary: if your prospects are in highly regulated industries (healthcare, legal, finance), email permission scope and data residency deserve a longer review than a typical SaaS contract gets. Don't shortcut that.

OKKI Go is probably a good fit for teams with 5–25 SDRs running structured outbound with a defined ICP. For everyone else, it's worth a trial—not a commitment.